219 related articles for article (PubMed ID: 23608200)
21. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
22. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
[TBL] [Abstract][Full Text] [Related]
23. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.
Kasongo KW; Shegokar R; Müller RH; Walker RB
Drug Dev Ind Pharm; 2011 Apr; 37(4):396-407. PubMed ID: 20923388
[TBL] [Abstract][Full Text] [Related]
24. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia).
Averina ES; Müller RH; Popov DV; Radnaeva LD
Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068
[TBL] [Abstract][Full Text] [Related]
25. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
26. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
27. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
28. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
29. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
30. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
32. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
33. Effect of surfactant on lycopene-loaded nanostructured lipid carriers.
Riangjanapatee P; Okonogi S
Drug Discov Ther; 2012 Jun; 6(3):163-8. PubMed ID: 22890207
[TBL] [Abstract][Full Text] [Related]
34. Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier.
Wang J; Tang J; Zhou X; Xia Q
Drug Dev Ind Pharm; 2014 Feb; 40(2):201-10. PubMed ID: 23336811
[TBL] [Abstract][Full Text] [Related]
35. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
[TBL] [Abstract][Full Text] [Related]
36. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.
Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y
Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327
[TBL] [Abstract][Full Text] [Related]
37. Preparation and in vitro characterization studies of astaxanthin-loaded nanostructured lipid carriers with antioxidant properties.
Gu L; Wang W; Wu B; Ji S; Xia Q
J Biomater Appl; 2023 Aug; 38(2):292-301. PubMed ID: 37452613
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels).
Teeranachaideekul V; Souto EB; Müller RH; Junyaprasert VB
J Microencapsul; 2008 Mar; 25(2):111-20. PubMed ID: 18246489
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of podophyllotoxin nanostructured lipid carriers and its effects on immortalized human cervical epithelial cells with HPV infection in vitro].
Chong SB; Zeng K; Li GF; Ren F; Zhu XL; Zhou JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1023-8. PubMed ID: 21690061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]